Effect of gonadotropin-releasing hormone agonist on the bone mineral density of patients with endometriosis

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (15)

• Gonadotropin releasing hormone agonist therapy and its effect on bone mass via openalex
• Reduced Bone Mass in Reproductive-Aged Women with Endometriosis* via openalex
• REVERSIBLE TRABECULAR BONE DENSITY LOSS FOLLOWING INDUCED HYPO‐OESTROGENISM WITH THE GnRH ANALOGUE BUSERELIN IN PREMENOPAUSAL WOMEN via openalex
• W2055260481 via openalex
• W2076408697 via openalex
• W2082950400 via openalex
• W2085496620 via openalex
• W2129449855 via openalex
• W2287757320 via openalex
• W2416265216 via openalex
• W2442024088 via openalex
• W2014486464 via openalex
• W6718602495 via openalex
• W2031495520 via openalex
• W2041617122 via openalex

Cited by (11)

• The effect of pharmacological cessation and restoration of menstrual cycle on bone metabolism in premenopausal women with endometriosis 2022
• Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest 2022
• Long-term treatment of endometriosis with dienogest for up to five years 2019
• Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study 2013
• Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial 2008
• Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density 2003
• Endometriosis: Treatment Strategies 2003
• Endometriosis: current concepts and therapy 2002
• Prolonged GnRH Agonist and Add-Back Therapy for Symptomatic Endometriosis 2002
• Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 2002
• Long-acting triptorelin for the treatment of endometriosis 1996

Source provenance

europepmc

last seen: 2026-06-13T06:22:48.782012+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:11:24.284338+00:00